Malignant gliomas are the most common and deadly brain tumors. Nevertheless, survival for
patients with glioblastoma, the most aggressive glioma, although individually variable, has …

Important advances have been made in the understanding and management of adult
gliomas and primary CNS lymphomas—the two most common primary brain tumours …

Combination therapy is increasingly becoming the cornerstone of current day antitumor
therapy. Glioblastoma multiforme is an aggressive brain tumor with a dismal median survival …

Glioblastoma (GBM) is the most common and lethal primary brain tumor. Over the past few
years tremendous genomic and proteomic characterization along with robust animal models …

The magnetic nanoparticle has emerged as a potential multifunctional clinical tool that can
provide cancer cell detection by magnetic resonance imaging (MRI) contrast enhancement …

The literature was reviewed to summarize the current understanding of the role of ciliated
ependymal cells in the mammalian brain. Previous reviews were summarized. Publications …

Glioblastoma (GBM) is composed of heterogeneous tumor cell populations, including those
with stem cell properties, termed glioma stem cells (GSCs). GSCs are innately less radiation …

MiRNA-34a is considered as a potential prognostic marker for glioma, as studies suggest
that its expression negatively correlates with patient survival in grade III and IV glial tumors …

MicroRNAs and cancer stem cells have emerged as critical players in glioblastoma, one of
the deadliest human cancers. In this study, we investigated the expression and function of …

Magnetic nanoparticles (MNPs) represent a promising nanomaterial for the targeted therapy
and imaging of malignant brain tumors. Conjugation of peptides or antibodies to the surface …